We are live on
!
Find out more
IAM
Iridian Asset Management Portfolio holdings
AUM
$291M
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
-24.94%
1 Year Est. Return
+49.45%
3 Year Est. Return
+82.55%
5 Year Est. Return
+101.12%
10 Year Est. Return
+450.66%
AUM
$4.13B
AUM Growth
-$1.97B
(-32%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-6.2%
Top 10 Holdings %
Top 10 Hldgs %
39.99%
Holding
92
New
15
Increased
30
Reduced
28
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$48.3M |
| 2 |
Axsome Therapeutics
AXSM
|
+$42.2M |
| 3 |
Charles River Laboratories
CRL
|
+$39.9M |
| 4 |
Qorvo
QRVO
|
+$38.5M |
| 5 |
Equifax
EFX
|
+$33.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Mills
GIS
|
+$175M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$123M |
| 3 |
Wyndham Hotels & Resorts
WH
|
+$82.6M |
| 4 |
WW
WW International
WW
|
+$78.6M |
| 5 |
Hilton Worldwide
HLT
|
+$63.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.74% |
| 2 | Technology | 18.13% |
| 3 | Industrials | 16.98% |
| 4 | Consumer Discretionary | 15.35% |
| 5 | Financials | 12.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Progressive
PGR
$125B
| $1.9M | 0.05% |
25,764
+413
| +2% | +$31.8K |
|
52
Berkshire Hathaway Class B
BRK.B
$1.13T
| $1.76M | 0.04% |
9,640
+1,331
| +16% | +$283K |
|
53
Meta Platforms (Facebook)
META
$1.51T
| $1.6M | 0.04% |
+9,602
| New | +$1.88M |
|
54
Halozyme
HALO
$12.2B
| $1.59M | 0.04% |
88,441
-19,562
| -18% | -$371K |
|
|
AVDL
55
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.26M | 0.03% |
+159,100
| New | +$1.22M |
|
56
Brookfield
BN
$108B
| $1.24M | 0.03% |
78,589
+5,805
| +8% | +$119K |
|
57
Innoviva
INVA
$1.48B
| $1.23M | 0.03% |
104,673
+2,673
| +3% | +$35.4K |
|
58
Perrigo
PRGO
$1.78B
| $1.23M | 0.03% |
25,581
-392
| -2% | -$21K |
|
|
SAFM
59
CALL
DELISTED
Sanderson Farms Inc
SAFM
| $1.15M | 0.03% |
+9,300
| New | +$1.3M |
|
60
Precigen
PGEN
$2.59B
| $1.11M | 0.03% |
327,103
+37,137
| +13% | +$160K |
|
|
61
Wyndham Hotels & Resorts
WH
$5.48B
| $884K | 0.02% |
28,066
-1,625,108
| -98% | -$82.6M |
|
62
CALL
Marathon Petroleum
MPC
$83.7B
| $803K | 0.02% |
+34,000
| New | +$1.57M |
|
63
Bloom Energy
BE
$64.6B
| $780K | 0.02% |
149,200
-10,417
| -7% | -$88.3K |
|
|
64
CALL
Axsome Therapeutics
AXSM
$10.9B
| $600K | 0.01% |
+10,200
| New | +$831K |
|
65
SPDR Gold Trust
GLD
$141B
| $595K | 0.01% |
+4,022
| New | +$599K |
|
|
66
PUT
Wyndham Hotels & Resorts
WH
$5.48B
| $495K | 0.01% |
+15,700
| New | +$798K |
|
|
AVDL
67
DELISTED
Avadel Pharmaceuticals
AVDL
| $481K | 0.01% |
60,600
-249,869
| -80% | -$1.92M |
|
|
AVDL
68
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
| $480K | 0.01% |
+60,500
| New | +$465K |
|
69
CALL
Post Holdings
POST
$3.57B
| $465K | 0.01% |
+8,557
| New | +$556K |
|
70
Marriott International
MAR
$92.3B
| $436K | 0.01% |
5,828
| – | – |
|
|
71
CALL
Precigen
PGEN
$2.59B
| $347K | 0.01% |
+102,200
| New | +$441K |
|
72
Albemarle
ALB
$15.5B
| $289K | 0.01% |
5,128
-3,076
| -37% | -$236K |
|
73
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $263K | 0.01% |
+2,606
| New | +$238K |
|
|
STR
74
DELISTED
Sitio Royalties
STR
| $230K | 0.01% |
26,796
| – | – |
|
|
MOMO
75
Hello Group
MOMO
$866M
| $227K | 0.01% |
+10,447
| New | +$311K |
|
Similar funds
DP
EPIME
DIGDR
LFC
ODFS
FPM
OCM
FFA
Iridian Asset Management's Q1 2020 Portfolio in Review
As of Q1 2020, Iridian Asset Management held 92 positions worth $4.13B, down 32% from $6.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Iridian Asset Management withdrew a net $256M in Q1 2020, closing 14 positions and reducing 28 holdings. Its most notable exit was Medicines Co, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
Against the trend, Iridian Asset Management opened a new position in Viatris worth $37.6M.
- Iridian Asset Management's largest Q1 2020 buy was Viatris: 2,520,235 shares worth $37.6M.
- Iridian Asset Management added most to Axsome Therapeutics in Q1 2020, an estimated $42.2M increase.
- Iridian Asset Management's biggest Q1 2020 reduction was General Mills, cutting an estimated $175M.
- Iridian Asset Management fully exited Medicines Co in Q1 2020, selling an estimated $123M.
- Iridian Asset Management's ten largest holdings make up 40% of its $4.13B portfolio in Q1 2020.
- Iridian Asset Management opened 15 new positions and closed 14 in Q1 2020.
- Iridian Asset Management's portfolio value fell 32% quarter-over-quarter to $4.13B.
Based on Iridian Asset Management's 13F filing for Q1 2020, filed 11 May 2020.